Home
About
Contact
Issue Archive
- 2019
- 2018
- 2017
Special Issues
- 2018 Third Annual Oncology Guide to New FDA Approvals
Current Issue

Sign Up Now!

To sign up for our newsletter or print publications, please enter your contact information below.

First Name *

Last Name *

Email Address *

Email Address (Verify) *

VBCC Print Edition

We will request your mailing address on the next page.

VBCC E-Newsletters & Communications

I have reviewed and consent to the terms of VBCC's Privacy Policy, and VBCC has my permission to retain my information in its database, and to forward pertinent communications to me.

AVBCC
Economics & Value
Personalized Medicine
- Solid Tumors
- Hematologic Malignancies
VBCM
Conference Correspondent
Web Exclusives
Videos

AVBCC
Economics & Value
Personalized Medicine
- Solid Tumors
- Hematologic Malignancies
VBCM
Conference Correspondent
Web Exclusives
Videos

Home
About
Contact
Issue Archive
- 2019
- 2018
- 2017
Special Issues
- 2018 Third Annual Oncology Guide to New FDA Approvals
Current Issue

SIRT + Sorafenib = No Survival Bump in Liver Cancer

(MedPage Today) — But clinical benefits suggested in certain patients with less severe disease Source link

Share this News Item:

facebook twitter email

Related News:

Alcohol, mortality, and cancer risk: Is moderation key?

There have been many studies on alcohol and its impact on health, but the relationship is not fully understood. A new, large-scale study investigates. Source link [ Read More ]

'This Is Not Good News': What We Heard This Week

(MedPage Today) — Quotable quotes from MedPage Today’s sources Source link [ Read More ]

We Want to Know

Are you discussing the cost of care with your patients?*
- Yes
- No

Can scientists learn to remove bad memories?

'I Think About the Lives Saved': What We Heard This Week

Little Benefit in Adding Ultrasound to Screening Mammography

Copyright 2019. Engage Healthcare Communications, LLC. All Rights Reserved. Privacy Policy. Sitemap.

We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site, you are agreeing to this use and our Privacy Policy.